Oxymorphone Extended Release in Patients With Cancer or Neuropathic Pain
NCT00911261
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
223
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Pain
Neuropathic Pain
Cancer
Interventions
DRUG:
Oxymorphone Extended Release
Sponsor
Endo Pharmaceuticals